BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25549970)

  • 1. Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    Launay N; Aguado C; Fourcade S; Ruiz M; Grau L; Riera J; Guilera C; Giròs M; Ferrer I; Knecht E; Pujol A
    Acta Neuropathol; 2015 Mar; 129(3):399-415. PubMed ID: 25549970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
    Launay N; Ruiz M; Grau L; Ortega FJ; Ilieva EV; Martínez JJ; Galea E; Ferrer I; Knecht E; Pujol A; Fourcade S
    Acta Neuropathol; 2017 Feb; 133(2):283-301. PubMed ID: 28004277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
    Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A
    Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    López-Erauskin J; Fourcade S; Galino J; Ruiz M; Schlüter A; Naudi A; Jove M; Portero-Otin M; Pamplona R; Ferrer I; Pujol A
    Ann Neurol; 2011 Jul; 70(1):84-92. PubMed ID: 21786300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
    Fourcade S; Ferrer I; Pujol A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):18-29. PubMed ID: 26073123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy.
    Launay N; Ruiz M; Fourcade S; Schlüter A; Guilera C; Ferrer I; Knecht E; Pujol A
    Brain; 2013 Mar; 136(Pt 3):891-904. PubMed ID: 23436506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
    Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
    Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A
    Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes.
    Singh J; Giri S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):126-31. PubMed ID: 24491542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
    Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy.
    Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A
    Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.
    Morató L; Ruiz M; Boada J; Calingasan NY; Galino J; Guilera C; Jové M; Naudí A; Ferrer I; Pamplona R; Serrano M; Portero-Otín M; Beal MF; Fourcade S; Pujol A
    Cell Death Differ; 2015 Nov; 22(11):1742-53. PubMed ID: 25822341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Bianchi P; Fourcade S; Andreu AL; Ferrer I; Muñoz-Pinedo C; Pujol A
    Brain; 2012 Dec; 135(Pt 12):3584-98. PubMed ID: 23250880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.
    Zhang Y; Vasheghani F; Li YH; Blati M; Simeone K; Fahmi H; Lussier B; Roughley P; Lagares D; Pelletier JP; Martel-Pelletier J; Kapoor M
    Ann Rheum Dis; 2015 Jul; 74(7):1432-40. PubMed ID: 24651621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.
    Ferrer I; Kapfhammer JP; Hindelang C; Kemp S; Troffer-Charlier N; Broccoli V; Callyzot N; Mooyer P; Selhorst J; Vreken P; Wanders RJ; Mandel JL; Pujol A
    Hum Mol Genet; 2005 Dec; 14(23):3565-77. PubMed ID: 16223892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model.
    Yamada T; Ohyagi Y; Shinnoh N; Kikuchi H; Osoegawa M; Ochi H; Kira J; Furuya H
    J Neurol Sci; 2004 Mar; 218(1-2):91-7. PubMed ID: 14759639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy.
    Parameswaran J; Goicoechea L; Planas-Serra L; Pastor A; Ruiz M; Calingasan NY; Guilera C; Aso E; Boada J; Pamplona R; Portero-Otín M; de la Torre R; Ferrer I; Casasnovas C; Pujol A; Fourcade S
    Acta Neuropathol; 2022 Aug; 144(2):241-258. PubMed ID: 35778568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model.
    Liu H; Qiu H; Xiao Q; Le W
    J Alzheimers Dis; 2015; 48(4):1019-32. PubMed ID: 26444766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.